Daniel Prieto-Alhambra

Health Data Sciences, Centre for Statistics in Medicine, University of Oxford, United Kingdom

Disclosure information not submitted.

Presentation(s):

• 1B-01 - DARWIN EU® - Background incidence rates of selected vaccine adverse events of special interest (AESIs) in Europe

  Sunday, August 24, 2025
  10:30 AM - 10:45 AM ET

• SW-1G - What can pharmacoepidemiologists do to enhance vaccine confidence?

  Sunday, August 24, 2025
  1:30 PM - 3:00 PM ET

• SW-2F - Overcoming Challenges in CDM Harmonization from Within-Country Coordination to International Collaboration

  Sunday, August 24, 2025
  5:15 PM - 6:45 PM ET

• 3A-04 - Comparative Effectiveness of Denosumab and Oral Bisphosphonates in UK and Danish Real World Data

  Monday, August 25, 2025
  9:00 AM - 9:15 AM ET

• 3E-02 - SLCO1B1 Functional Variants and Statin Efficacy Biomarkers: Analysis of 68,553 UK Biobank Users

  Monday, August 25, 2025
  8:30 AM - 8:45 AM ET

• 3E-06 - Association between genetic polymorphisms of interest and risk of myopathy among statin users: A proof-of-concept study in DARWIN EU

  Monday, August 25, 2025
  9:30 AM - 9:45 AM ET

• 5A-06 - DARWIN EU® - Antipsychotic prescribing in the general population in Europe: a descriptive analysis of trends and patient characteristics

  Tuesday, August 26, 2025
  9:45 AM - 10:00 AM ET

• 6G-03 - Comparison of baseline characteristics in patients with prostate cancer who received radical prostatectomy or external beam radiotherapy: target trial versus real-world data population

  Tuesday, August 26, 2025
  2:00 PM - 2:15 PM ET